The ACE2 gene: Its potential as a functional candidate for cardiovascular disease

Clinical Science

Volumn 124, Issue 2, 2013, Pages 65-76

  Burrell, Louise M ^a,b   Harrap, Stephen B ^a   Velkoska, Elena ^a   Patel, Sheila K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Angiotensin converting enzyme 2 (ACE2); Coronary artery disease; Hypertension; Left ventricular hypertrophy; Myocardial infarction; Renin angiotensin system (RAS)

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN II; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SYSTOLIC HEART FAILURE; X CHROMOSOME; BLOOD; BLOOD PRESSURE; GENETICS; HAPLOTYPE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE;

ANGIOTENSIN II; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; GENETIC VARIATION; HAPLOTYPES; HUMANS; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; SEX FACTORS;

EID: 84871878863     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120269     Document Type: Article

References (80)

1. Johnston, C. I. (1994) Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23, 258-268
2. Dzau, V. (2005) The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J. Hypertens. 23 (Suppl.), S9-S17
3. World Health Organization (2011) Global Atlas on cardiovascular disease prevention and control (Mendis, S., Puska, P. and Norrving, B., eds), World Health Organization, Geneva
4. Probstfield, J. L. and O'Brien, K. D. (2010) Progression of cardiovascular damage: the role of renin-angiotensin system blockade. Am. J. Cardiol. 105, 10A-20A
5. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9
6. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G. and Turner, A. J. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243
7. Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I. et al. (2005) Myocardial infarction increases ACE2 expression in rat and humans. Eur. Heart J. 26, 369-375
8. Ohtsuki, M., Morimoto, S., Izawa, H., Ismail, T. F., Ishibashi-Ueda, H., Kato, Y., Horii, T., Isomura, T., Suma, H., Nomura, M. et al. (2010) Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure. Int. J. Cardiol. 145, 333-334
9. Zulli, A., Burrell, L. M., Widdop, R. E., Black, M. J., Buxton, B. F. and Hare, D. L. (2006) Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J. Histochem. Cytochem. 54, 147-150
10. Zulli, A., Burrell, L. M., Buxton, B. F. and Hare, D. L. (2008) ACE2 and AT4R are present in diseased human blood vessels. Eur. J. Histochem. 52, 39-44
11. Sluimer, J. C., Gasc, J. M., Hamming, I., van Goor, H., Michaud, A., van den Akker, L. H., Jutten, B., Cleutjens, J., Bijnens, A. P., Corvol, P. et al. (2008) Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol. 215, 273-279
12. Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J. and Cooper, M. E. (2003) Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41, 392-397
13. Mizuiri, S., Hemmi, H., Arita, M., Ohashi, Y., Tanaka, Y., Miyagi, M., Sakai, K., Ishikawa, Y., Shibuya, K., Hase, H. and Aikawa, A. (2008) Expression of ACE and ACE2 in individuals with diabetic kidney disease and healty controls. Am. J. Kidney Dis. 51, 613-623
14. Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W. and Herzenberg, A. M. (2008) Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610-1616
15. Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L. and Lazartigues, E. (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R373-R381
16. Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Thomas, M. C., Lew, R. A., Yarski, M., Smith, A. I. and Cooper, M. E. (2004) Identification of angiotensin converting enzyme 2 in the rodent retina. Curr. Eye Res. 29, 419-427
17. Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M. and Angus, P. W. (2005) Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54, 1790-1796
18. Bernardi, S., Zennaro, C., Palmisano, S., Velkoska, E., Sabato, N., Toffoli, B., Giacomel, G., Buri, L., Zanconati, F., Bellini, G. et al. (2012) Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma. JRAAS 13, 202-209
19. Garg, M., Angus, P. W., Burrell, L. M., Herath, C., Gibson, P. R. and Lubel, J. S. (2012) The pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment. Pharmacol. Ther. 35, 414-428
20. Hamming, I., Timens, W., Bulthuis, M. L., Lely, A. T., Navis, G. J. and van Goor, H. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631-637
21. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F. et al. (2002) Hydrolysis of biological peptides by human angiotensinconverting enzyme-related carboxypeptidase. J. Biol. Chem. 277, 14838-14843
22. Tallant, E. A. and Clark, M. A. (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42, 574-579
23. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263
24. Burrell, L. M., Johnston, C. I., Tikellis, C. and Cooper, M. E. (2004) ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol. Metab. 15, 166-169
25. Chappel, M. C. and Ferrario, C. M. (2006) ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int. 70, 8-10
26. Clarke, N. E. and Turner, A. J. (2012) Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012, 307315
27. Tikellis, C., Bernardi, S. and Burns, W. C. (2011) Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 20, 62-68
28. Ferrario, C. M. and Varagic, J. (2010) The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am. J. Physiol. Renal Physiol. 298, F1297-F1305
29. Xu, P., Sriramula, S. and Lazartigues, E. (2011) ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R804-R817
30. Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M. and Turner, A. J. (2005) Tumor necrosis factor-a convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113-30119
31. Lambert, D. W., Clarke, N. E., Hooper, N. M. and Turner, A. J. (2008) Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett. 582, 385-390
32. Burchill, L., Velkoska, E., Dean, R. G., Lew, R. A., Smith, A. I., Levidiotis, V. and Burrell, L. M. (2008) Acute kidney injury in the rat causes cardiac remodelling and increases angiotensinconverting enzyme 2 expression. Exp. Physiol. 93, 622-630
33. Velkoska, E., Dean, R. G., Griggs, K., Burchill, L. and Burrell, L. M. (2011) Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clin. Sci. 120, 335-345
34. Lew, R. A., Warner, F. J., Hanchapola, I. and Smith, A. I. (2006) Characterization of angiotensin converting enzyme-2 (ACE2) in human urine. Int. J. Pept. Res. Ther. 12, 283-289
35. Lew, R. A., Warner, F. J., Hanchapola, I., Yarski, M. A., Manohar, J., Burrell, L. M. and Smith, A. I. (2008) Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol. 93, 685-693
36. Chong, C. P., Lim, W. K., Velkoska, E., van Gaal, W. J., Ryan, J. E., Savige, J. and Burrell, L. M. (2012) N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic Surgery. Am. J. Cardiol. 109, 1365-1373
37. Rice, G. I., Jones, A. L., Grant, P. J., Carter, A. M., Turner, A. J. and Hooper, N. M. (2006) Circulating activities of angiotensinconverting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension 48, 914-920
38. Masson, R., Nicklin, S. A., Craig, M. A., McBride, M., Gilday, K., Gregorevic, P., Allen, J. M., Chamberlain, J. S., Smith, G., Graham, D. et al. (2009) Onset of experimental severe cardiac fibrosis is mediated by overexpression of angiotensin-converting enzyme 2. Hypertension 53, 694-700
39. Keidar, S., Strizevsky, A., Raz, A. and Gamliel-Lazarovich, A. (2007) ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects. Nephrol. Dial. Transplant. 22, 597-601
40. Keidar, S., Gamliel-Lazarovich, A., Kaplan, M., Pavlotzky, E., Hamoud, S., Hayek, T., Karry, R. and Abassi, Z. (2005) Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ. Res. 97, 946-953
41. Epelman, S., Tang, W. H., Chen, S. Y., Van Lente, F., Francis, G. S. and Sen, S. (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J. Am. Coll. Cardiol. 52, 750-754
42. Epelman, S., Shrestha, K., Troughton, R. W., Francis, G. S., Sen, S., Klein, A. L. and Tang, W. H. (2009) Soluble angiotensinconverting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J. Card. Failure 15, 565-571
43. Wang, Y., Moreira Mda, C., Heringer-Walther, S., Ebermann, L., Schultheiss, H. P., Wessel, N., Siems, W. E. and Walther, T. (2010) Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. J. Card. Failure 16, 157-163
44. Soro-Paavonen, A., Gordin, D., Forsblom, C., Rosengard-Barlund, M., Waden, J., Thorn, L., Sandholm, N., Thomas, M. C. and Groop, P. H. (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 30, 375-383
45. Freeman, M., Patel, S. K., Lancefield, T., Velkoska, E., Griggs, K., Dean, R. G., Al-Fiadh, A., Horrigan, M., Farouque, H. M. O. and Burrell, L. M. (2011) Angiotensin converting enzyme 2: a novel marker of coronary artery disease. Eur. Heart J. 31, 515
46. Goulter, A. B., Goddard, M. J., Allen, J. C. and Clark, K. L. (2004) ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2, 19
47. International HapMap Consortium. (2003) The International HapMap Project. Nature 426, 789-796
48. Phillips, J. E. and Corces, V. G. (2009) CTCF: master weaver of the genome. Cell 137, 1194-1211
49. Zeng, Y., Wang, W., Ma, J., Wang, X., Guo, M. and Li, W. (2012) Knockdown of ZNF268, which is transcriptionally downregulated by GATA-1, promotes proliferation of K562 cells. PLoS ONE 7, e29518
50. Vignon-Zellweger, N., Heiden, S. and Emoto, N. (2011) Renal function and blood pressure: molecular insights into the biology of endothelin-1. Contrib. Nephrol. 172, 18-34
51. Australian Institute of Health and Welfare (2011) Cardiovascular disease: Australian facts in Cardiovascular disease series, Australian Institute of Health and Welfare, Canberra
52. Berletch, J. B., Yang, F., Xu, J., Carrel, L. and Disteche, C. M. (2011) Genes that escape from X inactivation. Hum. Genet. 130, 237-245
53. Carrel, L. and Willard, H. F. (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400-404
54. Talebizadeh, Z., Simon, S. D. and Butler, M. G. (2006) X chromosome gene expression in human tissues: male and female comparisons. Genomics 88, 675-681
55. Huang, W., Yang, W., Wang, Y., Zhao, Q., Gu, D. and Chen, R. (2006) Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese. J. Hum. Hypertens. 20, 968-971
56. Yi, L., Gu, Y. H., Wang, X. L., An, L. Z., Xie, X. D., Shao, W., Ma, L. Y., Fang, J. R., An, Y. D., Wang, F. and Zhang, D. L. (2006) Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J. Int. Med. Res. 34, 272-283
57. Niu, W., Qi, Y., Hou, S., Zhou, W. and Qiu, C. (2007) Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Transl. Res. 150, 374-380
58. Fan, X., Wang, Y., Sun, K., Zhang, W., Yang, X., Wang, S., Zhen, Y., Wang, J., Li, W., Han, Y. et al. (2007) Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. Clin. Pharmacol. Ther. 82, 187-196
59. Fan, X. H., Wang, Y. B., Wang, H., Sun, K., Zhang, W. L., Song, X. D., Cheng, J. Z., Wu, H. Y., Zhou, X. L. and Hui, R. T. (2009) Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients. Acta Pharmacol. Sin. 30, 1237-1244
60. Zhao, Q., Gu, D., Kelly, T. N., Hixson, J. E., Rao, D. C., Jaquish, C. E., Chen, J., Huang, J., Chen, C. S., Gu, C. C. et al. (2010) Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. Am. J. Hypertens. 23, 606-613
61. Zhao, Q., Hixson, J. E., Rao, D. C., Gu, D., Jaquish, C. E., Rice, T., Shimmin, L. C., Chen, J., Cao, J., Kelly, T. N. et al. (2010) Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study. J. Hypertens. 28, 756-763
62. Zhong, J., Yan, Z., Liu, D., Ni, Y., Zhao, Z., Zhu, S., Tepel, M. and Zhu, Z. (2006) Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J. Lab. Clin. Med. 147, 91-95
63. Song, S. B., Jin, H. S., Hong, K. W., Lim, J. E., Moon, J. Y., Jeong, K. H., Ihm, C. G., Lee, T. W., Oh, B. and Lee, S. H. (2011) Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population. Blood Press. 20, 204-210
64. Benjafield, A. V., Wang, W. Y. and Morris, B. J. (2004) No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am. J. Hypertens. 17, 624-628
65. Patel, S. K., Wai, B., Ord, M., Macisaac, R. J., Grant, S., Velkoska, E., Panagiotopoulos, S., Jerums, G., Srivastava, P. M. and Burrell, L. M. (2012) Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in caucasians with type 2 diabetes. Am. J. Hypertens. 25, 216-222
66. Lieb, W., Graf, J., Gotz, A., Konig, I. R., Mayer, B., Fischer, M., Stritzke, J., Hengstenberg, C., Holmer, S. R., Doring, A. et al. (2006) Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J. Mol. Med. 84, 88-96
67. Zhou, J. B. and Yang, J. K. (2009) Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension. JRAAS 10, 31-34
68. Lu, N., Yang, Y., Wang, Y., Liu, Y., Fu, G., Chen, D., Dai, H., Fan, X., Hui, R. and Zheng, Y. (2012) ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects. Mol. Biol. Rep. 39, 6581-6589
69. Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y. et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 822-828
70. Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T. A., Donoghue, M., Breitbart, R. E., Acton, S. L. et al. (2006) Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Invest. 116, 2218-2225
71. Bodiga, S., Zhong, J. C., Wang, W., Basu, R., Lo, J., Liu, G. C., Guo, D., Holland, S. M., Scholey, J. W., Penninger, J. M. et al. (2011) Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit. Cardiovasc. Res. 91, 151-161
72. Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S. et al. (2006) Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 47, 718-726
73. Wang, S. X., Fu, C. Y., Zou, Y. B., Wang, H., Shi, Y., Xu, X. Q., Chen, J. Z., Song, X. D., Huan, T. J. and Hui, R. T. (2008) Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. Chin. Med. J. 121, 27-31
74. van der Merwe, L., Cloete, R., Revera, M., Heradien, M., Goosen, A., Corfield, V. A., Brink, P. A. and Moolman-Smook, J. C. (2008) Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy. Hum. Genet. 124, 57-61
75. Kelly, M., Bagnall, R. D., Peverill, R. E., Donelan, L., Corben, L., Delatycki, M. B. and Semsarian, C. (2011) A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia. J. Mol. Cell. Cardiol. 51, 848-854
76. Palmer, B. R., Jarvis, M. D., Pilbrow, A. P., Ellis, K. L., Frampton, C. M., Skelton, L., Yandle, T. G., Doughty, R. N., Whalley, G. A., Ellis, C. J. et al. (2008) Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am. Heart J. 156, 752-758
77. Yang, W., Huang, W., Su, S., Li, B., Zhao, W., Chen, S. and Gu, D. (2006) Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Clin. Sci. 111, 333-340
78. Vangjeli, C., Dicker, P., Tregouet, D. A., Shields, D. C., Evans, A. and Stanton, A. V. (2011) A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project. JRAAS 12, 504-509
79. Sotoodehnia, N., Li, G., Johnson, C. O., Lemaitre, R. N., Rice, K. M., Rea, T. D. and Siscovick, D. S. (2009) Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk. Heart Rhythm 6, 1306-1314
80. Turner, A. J. and Hooper, N. M. (2002) The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol. Sci. 23, 177-183